Director & 10% Owner Robert Duggan Buys $13M in Open Market

summarizeSummary

Pulse Biosciences Director and 10% owner Robert W. Duggan purchased nearly $13 million worth of common stock in an open market transaction, signaling strong conviction.

check_boxKey Events

• Director & 10% Owner Makes Large Purchase

  Robert W. Duggan, a Director and 10% owner, acquired 660,233 shares of common stock for approximately $13 million at an average price of $19.69 per share.

• Significant Insider Confidence

  This open market purchase, representing nearly 1% of the company's market capitalization, demonstrates strong conviction from a key insider.

• ATM Program Used for Acquisition

  The shares were acquired through the company's existing at-the-market (ATM) equity offering program, as noted in the filing footnotes.

auto_awesomeAnalysis

This significant open market purchase by Robert W. Duggan, who serves as both a Director and a 10% owner, demonstrates substantial insider confidence in Pulse Biosciences. The acquisition of nearly $13 million in shares, representing almost 1% of the company's market capitalization, is a material investment and stands out as a strong positive signal, especially following recent positive clinical data and strategic realignments.